Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -64.13-23.46-24.787.6324.25

What is the latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS is -64.13 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-64.13
Mar2025-23.46
Mar2024-24.78
Mar20237.63
Mar202224.25

How is Core EBITDA Growth of BALAXI PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2026 -64.13
Negative
Mar2025 -23.46
Negative
Mar2024 -24.78
Negative
Mar2023 7.63
-68.54
Mar2022 24.25 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹121.9 Cr -1.2% -5.3% -49.1% Stock Analytics
ADANI ENTERPRISES ₹363,881.0 Cr 2.2% -8.1% 9.2% Stock Analytics
ADITYA INFOTECH ₹49,843.6 Cr -1.7% 14.6% 195.5% Stock Analytics
AEGIS LOGISTICS ₹47,955.4 Cr -5.8% -1.1% 73.5% Stock Analytics
PREMIER ENERGIES ₹41,082.6 Cr -0.3% 0.7% -11% Stock Analytics
REDINGTON ₹29,992.8 Cr -1.9% -1.2% 35.1% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-1.2%

-5.3%

-49.1%

SENSEX

3.1%

1%

-9.1%


You may also like the below Video Courses